A Randomized, Double-Blind, Multicenter, Placebo-Controlled, Phase 2 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Itraconazole Administered as a Dry Powder for Inhalation (PUR1900) in Adult Asthmatic Patients With Allergic Bronchop

Project: Other project

Project Details

StatusFinished
Effective start/end date7/15/197/14/21

Funding

  • Pulmatrix, Inc.: $7,461.54